The aim of this study was to observe the effects of adrenomedullin (ADM) on endothelin (ET) production induced by urotensin II (U II) in rat vascular smooth muscle cells (VSMCs). Cultured VSMCs which were incubated with U II (10−8 mol/L) and with various concentrations of ADM were used to measure the VSMCs 3H-TdR incorporation, the activity of extracellular signal-regulated kinase (ERK), the amount of ET mRNA and ET production in VSMCs. In this work we found that incubation with U II (10−8 mol/L) increased obviously the amount of ET mRNA in VSMCs and ET production in medium, however, co-incubation with ADM (10−10– 10−8 mol/L) and U II(10−8 mol/L) reduced the amount of ET mRNA by 15%, 24% and 45% (P< 0.01) respectively, compared with U II alone. The content of ET in medium was 14.13, 11.38 and 11.00 pg/mL. ADM alone (10−8 mol/L) had no effect on ET production in VSMCs. U II (10−8 mol/L) promoted the 3H-TdR incorporation and activity of ERK in VSMCs. ADM inhibited VSMCs 3H-TdR incorporation and activation of ERK in a concentration-dependent manner. Compared with U II group, after co-incubation with ADM (10−10–10−8 mol/L) and U II (10−8 mol/L) the VSMCs 3H-TdR incorporation was decreased by 7% (P > 0.05), 32% (P < 0.05) and 41% (P < 0.01), respectively, and the activity of ERK was decreased by 24% (P > 0.05), 32% (P < 0.05) and 36% (P < 0.05), respectively, in a concentration-dependent manner. The results show that in cultured VSMCs ADM inhibits ET mRNA expression, ET production and proliferation stimulated by U II, and that inhibitory effect of ADM on U II bioaction could be mediated through inhibiting MAPK pathway.
This is a preview of subscription content, access via your institution.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Coulouarn, Y., Jegou, S., Tostivint, H. et al., Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors, FEBS Lett., 1999, 457(1): 28.
Coulouarn, Y., Fernex, C., Jegou, S. et al., Specific expression of the urotensin II gene in sacral motoneurons of developing rat spinal cord, Mechanism of Development, 2001, 101: 187.
Ames, R. S., Sarau, H. M., Chambers, J. K. et al., Human urotensinII: a potent vasoconstrictor and agonist for the orphan receptor GPR14, Nature, 1999, 401: 282.
Liu, Q., Pong, S. S., Zeng, Z. et al., Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14, Biochem. Biophys. Res. Commun., 1999, 266(1): 174.
Mori, M., Sugo, T., Abe, M. et al., Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14), Biochem. Biophys. Res. Commun., 1999, 265(1): 123.
Zhang, Y. G., Qi, Y. F., Xia, C. F. et al., Stimulating proliferation of aorta smooth muscle cells of rat urotensin II, Chinese Pharmacological Bulletin, 2001, 17(2): 155.
Watanabe, T., Pakala, R., Katagiri, T. et al., Synergistic effect of urotensin ii with mildly oxidized LdL on DNA synthesis in vascular smooth muscle cells, Circulation, 2001, 104(1): 16.
Sauzeau, V. Le, Mellionnec, E., Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase, Circ. Res., 2001, 88(11): 1102.
Qi, Y. F., Bu, D. F., Liu, D. D. et al., Urotensin II increases endothelin production by vascular smooth muscle cells in rats, Chinese Science Bulletin, 2002, 47(2): 289.
Owji, A. A., Smith, D. M., Coppock, H. A. et al., An abundant and specific binding site for the novel vasodilator adreomedullin in the rat, Endocrinology, 1995, 136(5): 2127.
Hinson, J. P., Kapas, S., Smith, D. M., Adrenomdullm, a multifunctional regulatory peptide, Endocrin Reviews, 2000, 21(2): 138.
Campbell, J. H., Campbell, G. R., Culture techniques and their applications to studies of vascular smooth muscle, Clin. Sci., 1993, 85: 501.
Li, T. C., Pang, Y. Z., Su, J. Y. et al., Measurement of activity of mitogenic activated protein kinase, Basic Medical Sciences and Clinics, 1996, 16(2): 78.
Celi, F. S., Zenilman, M. E., Shuldiner, A. R., A rapid and versatile method to synthesize internal standards for competitive PCR, Nucleic Acids Research, 1993, 21(4): 1047.
Siebert, P. D., Larrick, J. W., Competitive PCR, Nature, 1992, 359: 557.
Tsai, S. J., Wiltbank, M. C., Standard curve quantitative competitive RT-PCR (SC-QC-RT-PCR): a simple method to quantify absolute concentration of mRNA from limited amounts of samples, in Gene Cloning and Analysis by RT-PCR (eds. Siebert, P. D., Larrick, J. W.), Natick, MA: Biotechniques Books, 1998, 91.
Hill, C. S., Treisman, R., Transcriptional regulation by extracellular signals: mechanisms and specificity, Cell, 1995, 80: 199.
Li, T. C., Tian, Q., Zhao, D. et al., Adrenomedullin inhibits the ET-induced proliferation of vascular smooth muscle cells, Chinse Jounal of Hypertension, 1996, 4(3): 171.
About this article
Cite this article
Qi, Y., Bu, D., Yang, J. et al. Adrenomedullin inhibits the endothelin production induced by urotensin II in rat vascular smooth muscle cells. Chin.Sci.Bull. 47, 1457–1461 (2002). https://doi.org/10.1360/02tb9321
- urotensin II